Table 1.

Summary of pediatric case reports in literature.

References	Age	Sex	Clinical presentation	Treatment	Time of follow-up	Outcomes
Mackay et al. (18)	16	F	Failure to thrive, jaundice, non-erosive arthritis, oral aphthous lesions	Cortisone	Not reported	Progression
Usta et al. (3)	12	F	Jaundice, hepatosplenomegaly, polyarthralgia, malaise, arthritis, butterfly-type facial erythema	Prednisolone Hydroxychloroquine Chloroquine	3 years	Stationary
Deen et al. (19)	13	M	Articular involvement, cardiopulmonary involvement	Prednisolone Azathioprine Chloroquine	Not reported	Remission
	13	F	Splenomegaly, articular involvement	Prednisolone Azathioprine Chloroquine	Not reported	Remission
	17	F	Jaundice, ascites, cutaneous involvement, proteinuria > 0.5 g/day, cardiopulmonary involvement	Prednisolone Azathioprine Chloroquine	Not reported	Remission
	11	F	Jaundice, cutaneous involvement, articular involvement, proteinuria > 0.5 g/day, cardiopulmonary involvement	Prednisolone Azathioprine Chloroquine	Not reported	Remission
Lai et al. (2015)	16	F	Jaundice, cholestatic hepatitis, malaise, butterfly-type facial erythema	Prednisolone Azathioprine Hydroxychloroquine	3 years	Remission
Battagliotti et al. (13)	16	F	Jaundice, renal and articular involvement, butterfly-type facial erythema	Prednisolone Mycophenolate mofetil	2 years	Remission

Revised from the Table 1 of Beisel et al. (17).